Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant GM-CSF Treatment and Modulation of Immune Cell Profile of the SLN in Melanoma

NCT02451488 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02451488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02451488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant GM-CSF Treatment and Modulation of Immune Cell Profile of the SLN in Melanoma
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2015
Completion date
November 4, 2016
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma